NDCHealth provides data on the leading drugs used by hospitals in 2003 based on wholesale acquisition cost
Temtokibart Shows Efficacy in Treatment of Atopic Dermatitis
The therapy achieved positive results during a phase 2b trial on the primary endpoint of percent change in Eczema Area and Severity Index (EASI) score.
Demystifying PBMs, Their Role in the Drug Supply Chain
President of 3 Axis Advisors and CEO of 46brooklyn Research joins Drug Topics to discuss nuances surrounding pharmacy benefit managers and the way they are perceived in the public eye.
ACE Inhibitors Show Lower Risk of MACE for Older Patients With Type 2 Diabetes
Angiotensin-converting enzyme inhibitors have been known to be more effective in decreasing the incidence of major adverse cardiac events for patients with diabetes.
Scripted for Her: Helping Patients Choose Contraceptive Methods
In this episode of the podcast, Natalie DiPietro Mager, PharmD, PhD, sits down with Jasmine Cutler, PharmD, CPh.
Calories to Satiation Predicts Patients Likely to Experience Adverse Events From GLP-1s
Patients often have anxiety about potential adverse effects, and experiencing adverse effects can affect patient adherence.
Bemnifosbuvir, Ruzasvir Regimen Shows Strong Efficacy as HCV Treatment
A phase 2 study found 95% of patients achieved a sustained virologic response at 12 weeks regardless of treatment adherence.